You can meet our newly combined MilliporeSigma team at Booth #821 in the exhibit hall throughout the conference – come learn how we have increased our biopharmaceutical manufacturing products and services through a combined portfolio.
We are always working to minimize the drug manufacturing complexity, improve productivity, reduce risk, lower cost and give you the confidence to manufacture safe, life-enhancing drugs to market.
“Go Beyond: How the Biopharma Risk Equation is Changing and Strategies to Manage for the Future” presented by Andrew Bulpin, Head of Process Solutions Strategic Marketing & Innovation
Be sure to pick up your copy of The Economist Intelligence Unit survey of global biopharma executives on risks, opportunities, and the future of the industry–stop by the booth or click here.